+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

REZAFUNGIN - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

REZAFUNGIN - Emerging Insight and Market Forecast - 2030

  • Report
  • December 2020
  • 60 Pages
  • Global
From
IBREXAFUNGERP - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

IBREXAFUNGERP - Emerging Insight and Market Forecast - 2030

  • Report
  • December 2020
  • 60 Pages
  • Global
From
Ilaris - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Ilaris - Drug Insight and Market Forecast - 2030

  • Report
  • December 2020
  • 60 Pages
  • Global
From
Casimersen - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Casimersen - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Givinostat - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Givinostat - Emerging Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Inclisiran - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Inclisiran - Emerging Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Ganaxolone - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Ganaxolone - Emerging Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Pemphigus Vulgaris - Pipeline Insight, 2025 - Product Thumbnail Image

Pemphigus Vulgaris - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sleep Apnea - Pipeline Insight, 2025 - Product Thumbnail Image

Sleep Apnea - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sarcopenia - Pipeline Insight, 2025 - Product Thumbnail Image

Sarcopenia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Celiac Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Celiac Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Chronic And Acute Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic And Acute Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bullous Pemphigoid - Pipeline Insight, 2025 - Product Thumbnail Image

Bullous Pemphigoid - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Generalized Anxiety Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Generalized Anxiety Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Myositis - Pipeline Insight, 2025 - Product Thumbnail Image

Myositis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Parkinson's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Parkinson's Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 280 Pages
  • Global
From
From
From
Neuromyelitis Optica Spectrum Disorder (NMOSD) - Pipeline Insight, 2025 - Product Thumbnail Image

Neuromyelitis Optica Spectrum Disorder (NMOSD) - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Thyroid Eye Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Thyroid Eye Disease - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more